mRNA-1645-CoreG28v2
- Generic Name
- mRNA-1645-CoreG28v2
Safety and Immunogenicity of MRNAs Encoding HIV Immunogens (eOD-GT8 60mer, Core-g28v2 60mer, N332-GT5 Gp151) in Adult Participants Without HIV and in Overall Good Health in South Africa (HVTN 317)
Phase 1
Not yet recruiting
- Conditions
- HIV Infections
- Interventions
- First Posted Date
- 2024-11-19
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- HIV Vaccine Trials Network
- Target Recruit Count
- 96
- Registration Number
- NCT06694753
- Locations
- 🇿🇦
Setshaba Research Centre CRS, Soshanguve, Gauteng, South Africa
🇿🇦Soweto HVTN CRS, Soweto, Gauteng, South Africa
🇿🇦Chatsworth CRS, Chatsworth, Kwa Zulu Natal, South Africa
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath